See more : Cooks Coffee Company Limited (CCC.NZ) Income Statement Analysis – Financial Results
Complete financial analysis of Thonburi Healthcare Group Public Company Limited (THG.BK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Thonburi Healthcare Group Public Company Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Celanese Corporation (CE) Income Statement Analysis – Financial Results
- Lok’nStore Group Plc (LOK.L) Income Statement Analysis – Financial Results
- Montea Comm. VA (MONT.BR) Income Statement Analysis – Financial Results
- Banco do Nordeste do Brasil S.A. (BNBR3.SA) Income Statement Analysis – Financial Results
- Assystem S.A. (0OA7.L) Income Statement Analysis – Financial Results
Thonburi Healthcare Group Public Company Limited (THG.BK)
About Thonburi Healthcare Group Public Company Limited
Thonburi Healthcare Group Public Company Limited, together with its subsidiaries, operates private hospitals in Thailand. The company operates through three segments: Medical Services Business, Healthcare Solution Provider, and Other Business. It offers services in various medical fields, including brain and neurology, bone and joint, gastro intestinal and liver, heart, and obstetrics and gynecology; and management services for provincial state hospitals, as well as for heart centers in the public and private sectors. The company also offers senior care and senior living, and home healthcare services; operates the patient rehabilitation center; conducts housing business for elderly; and operates care center and elderly carecenter, as well as distributes dental supplies brands, such as Adec, W&H, AO, Heraeus, Ivoclar, Megagen, SAM, Melag, and Alpro. It also sells pharmaceutical and medical goods in specialised stores; develops hospital management software; and develops land and property. The company operates four Bangkok-based hospitals, such as Thonburi, Thonburi 2, Thonburi Bamrungmuang hospitals, and Thonburi Burana Hospital, Pathum Thani; and four provincial hospitals, including Rajyindee, Ubonrak Thonburi, Sirivej Chanthaburi, and Thonburi Thungsong hospitals, as well as one hospital in the Republic of the Union of Myanmar. Thonburi Healthcare Group Public Company Limited was founded in 1976 and is headquartered in Bangkok, Thailand.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.84B | 11.54B | 10.85B | 7.31B | 8.23B | 7.09B | 6.61B | 6.23B | 5.79B | 5.51B |
| Cost of Revenue | 7.44B | 8.05B | 7.41B | 5.75B | 6.37B | 5.19B | 4.78B | 4.52B | 4.26B | 3.98B |
| Gross Profit | 2.40B | 3.49B | 3.44B | 1.57B | 1.87B | 1.91B | 1.83B | 1.71B | 1.53B | 1.54B |
| Gross Profit Ratio | 24.43% | 30.21% | 31.73% | 21.42% | 22.67% | 26.90% | 27.68% | 27.46% | 26.40% | 27.86% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.58B | 1.51B | 1.38B | 1.18B | 1.17B | 1.11B | 803.27M | 723.91M | 656.35M | 666.60M |
| Selling & Marketing | 229.60M | 210.07M | 182.84M | 224.57M | 223.53M | 264.28M | 202.13M | 130.93M | 124.58M | 97.58M |
| SG&A | 1.81B | 1.72B | 1.57B | 1.40B | 1.40B | 1.38B | 1.01B | 854.84M | 780.93M | 764.18M |
| Other Expenses | 0.00 | 196.53M | 65.06M | 67.99M | 94.52M | 70.86M | 88.95M | -97.93M | -99.83M | -119.27M |
| Operating Expenses | 1.81B | 1.72B | 1.57B | 1.40B | 1.40B | 1.38B | 1.01B | 756.91M | 681.10M | 644.91M |
| Cost & Expenses | 9.25B | 9.77B | 8.97B | 7.15B | 7.76B | 6.56B | 5.79B | 5.28B | 4.94B | 4.62B |
| Interest Income | 6.06M | 14.37M | 3.56M | 8.91M | 5.99M | 2.16M | 1.14M | 2.12M | 0.00 | 0.00 |
| Interest Expense | 449.48M | 302.11M | 296.23M | 278.39M | 214.26M | 144.10M | 160.25M | 177.12M | 162.81M | 223.00M |
| Depreciation & Amortization | 1.14B | 1.01B | 943.66M | 826.42M | 481.09M | 335.11M | 281.73M | 238.69M | 125.61M | 218.37M |
| EBITDA | 2.08B | 3.13B | 2.92B | 1.10B | 1.11B | 1.05B | 1.13B | 1.12B | 926.27M | 932.91M |
| EBITDA Ratio | 21.10% | 27.13% | 26.88% | 15.01% | 13.53% | 13.77% | 17.11% | 18.41% | 15.36% | 16.83% |
| Operating Income | 591.71M | 2.12B | 1.97B | 271.31M | 500.80M | 530.07M | 825.03M | 704.46M | 763.46M | 709.91M |
| Operating Income Ratio | 6.01% | 18.41% | 18.18% | 3.71% | 6.08% | 7.47% | 12.48% | 11.31% | 13.19% | 12.87% |
| Total Other Income/Expenses | -99.46M | 268.13M | -141.98M | -113.09M | 120.36M | -46.68M | -142.13M | -150.95M | 0.00 | 0.00 |
| Income Before Tax | 492.25M | 2.03B | 1.73B | 49.25M | 589.89M | 483.39M | 682.90M | 704.46M | 763.46M | 709.91M |
| Income Before Tax Ratio | 5.00% | 17.60% | 15.98% | 0.67% | 7.17% | 6.81% | 10.33% | 11.31% | 13.19% | 12.87% |
| Income Tax Expense | 100.12M | 354.40M | 377.11M | 26.43M | 130.12M | 116.71M | 117.95M | 160.47M | 181.64M | 150.77M |
| Net Income | 295.41M | 1.60B | 1.34B | 22.81M | 462.39M | 347.60M | 553.84M | 511.15M | 551.83M | 538.24M |
| Net Income Ratio | 3.00% | 13.88% | 12.33% | 0.31% | 5.62% | 4.90% | 8.38% | 8.21% | 9.54% | 9.76% |
| EPS | 0.35 | 1.89 | 1.59 | 0.03 | 0.54 | 0.41 | 0.72 | 0.69 | 0.72 | 0.70 |
| EPS Diluted | 0.35 | 1.89 | 1.59 | 0.03 | 0.54 | 0.41 | 0.72 | 0.69 | 0.65 | 0.63 |
| Weighted Avg Shares Out | 847.47M | 847.35M | 843.81M | 846.06M | 849.08M | 849.08M | 771.53M | 741.20M | 764.08M | 764.08M |
| Weighted Avg Shares Out (Dil) | 847.47M | 847.35M | 843.81M | 846.06M | 849.08M | 849.08M | 771.53M | 741.20M | 849.08M | 849.08M |
Source: https://incomestatements.info
Category: Stock Reports